Welcome to our dedicated page for Lument Finance Trust SEC filings (Ticker: LFT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lument Finance Trust, Inc.'s SEC filings document the governance, capital structure and financing activity of a Maryland commercial real estate debt investor. Its records identify listed common stock and 7.875% Series A Cumulative Redeemable Preferred Stock, and include definitive proxy materials covering annual meeting procedures, director elections, shareholder voting matters and board oversight.
Recent 8-K filings report quarterly and annual results, supplemental financial information, dividend disclosures, material definitive agreements and portfolio-financing transactions. The filing record includes disclosures on commercial real estate collateralized loan obligations, repurchase financing for commercial mortgage loan debt, credit and guaranty agreement amendments, subsidiary-level arrangements and transactions involving affiliates of the company's external manager.
Lument Finance Trust, Inc. is a Maryland REIT focused on transitional, floating-rate commercial real estate loans, primarily middle‑market multifamily, externally managed by Lument Investment Management, a subsidiary of ORIX USA. As of December 31, 2025, its loan portfolio comprised 61 senior secured floating‑rate loans with unpaid principal of $1.14 billion, a weighted average coupon of 7.2% and 1.7 years remaining term, with 92.7% backed by multifamily properties.
The company also held three multifamily REO properties with carrying value of $49.1 million and mortgage servicing rights on $54.6 million of unpaid principal. Financing totaled $996.6 million against capacity of $1.30 billion, including a new $663.8 million managed CLO providing $585.0 million of non‑mark‑to‑market funding. LFT uses leverage through CLOs, repurchase agreements and term facilities and highlights risks from interest‑rate volatility, credit performance, regulatory change, competition and maintaining REIT qualification.
Lument Finance Trust, Inc. amended its secured term loan Credit and Guaranty Agreement with Cortland Capital Market Services and existing lenders. A Fifth Amendment extended the maturity date of the secured term loans to February 20, 2026. A subsequent Sixth Amendment further revised key terms.
Under the Amended Credit and Guaranty Agreement, borrowings under the secured term loans now bear interest at a fixed rate of 9.75% per annum. The rate is scheduled to step up by 0.50% per annum for the first three months after February 20, 2029, with additional 0.50% step-ups every three months thereafter until maturity. The company agreed to pay lenders a customary fee for entering the Sixth Amendment and to reimburse certain lender expenses related to both amendments.
Lument Finance Trust director reports indirect common stock purchase. A person associated with director Walter C. Keenan reported an indirect acquisition of 25,000 shares of Lument Finance Trust, Inc. common stock on 12/30/2025 at a price of $1.4579 per share. After this transaction, a total of 197,116 common shares were reported as indirectly owned, with the nature of ownership described as "by wife." The filing is made as a single‑person report and does not include any derivative securities activity.
Lument Finance Trust director reported open-market purchases of common stock, increasing their direct ownership stake. On 12/18/2025, the director bought 795 shares of Lument Finance Trust common stock at a price of $1.50 per share. On 12/19/2025, they bought an additional 9,205 shares at $1.49 per share. Following these transactions, the director directly beneficially owned 172,116 shares of Lument Finance Trust common stock.
Lument Finance Trust, Inc. disclosed that a consolidated subsidiary closed LMNT CRE 2025-FL3, a commercial real estate collateralized loan obligation. The issuer sold approximately $585.0 million of investment grade notes to institutional investors and approximately $78.8 million of below investment grade notes to another LFT subsidiary, financing a portfolio of collateral interests and cash with a face value of about $663.8 million tied mainly to first-lien commercial mortgage bridge loans. Proceeds also repaid borrowings under existing credit facilities, funded a reinvestment account and covered transaction costs.
The structure includes multiple note classes with monthly interest payments at an initial weighted average rate of about 1.91% plus Term SOFR and a stated maturity in July 2043, with various optional and mandatory redemption features and limited recourse to the underlying collateral. LFT’s external manager and an affiliate waived fees on collateral management and advancing roles, while LFT affiliates retain at least 5% of the economic interest through Class H income notes to meet U.S. and European risk-retention rules.
LFT also arranged a new loan agreement with Northeast Bank providing up to $50 million of advances over a 36-month draw period to finance commercial real estate loans and REO properties at term SOFR plus a 3.50% margin, subject to borrowing base limits. In addition, the company declared a cash dividend of $0.04 per share on its common stock and $0.4921875 per share on its 7.875% Series A preferred stock.
Lument Finance Trust, Inc. reported that its Chief Financial Officer purchased additional company stock. On 12/01/2025, the officer acquired 10,000 shares of common stock in an open market transaction at a price of $1.6055 per share, coded as a purchase. Following this transaction, the officer beneficially owns 61,950 shares of Lument Finance Trust common stock held directly.
Lument Finance Trust, Inc. reported open-market stock purchases by its Chief Financial Officer. On November 26, 2025, the CFO bought 2,000 shares of common stock at $1.5962 per share. On November 28, 2025, the CFO bought an additional 1,200 shares at $1.62 per share.
After these transactions, the CFO beneficially owned 51,950 shares of Lument Finance Trust common stock in direct ownership. The filing does not report any derivative securities activity.
Lument Finance Trust, Inc. reported that its indirect subsidiary, Lument Commercial Mortgage Trust, entered into a Forward Purchase Agreement with Lument Structured Finance, LLC to buy seven mortgage assets. These Mortgage Assets have an aggregate unpaid principal balance of $135.6 million, and the aggregate purchase price is also $135.6 million plus accrued and unpaid interest as of the settlement date. The loans are first-lien, floating-rate mortgages or participation interests secured by six multifamily properties and one healthcare property across the United States. The settlement date is defined as December 10, 2025, or another date agreed by the parties. The company also announced the pricing of a commercial real estate collateralized loan obligation, LMNT 2025-FL3, through certain of its wholly owned subsidiaries, as described in a press release furnished as an exhibit.
Lument Finance Trust, Inc. (LFT) reported a routine insider equity transaction by one of its directors. On 11/24/2025, the director received 16,351 shares of LFT common stock as compensation, described as director fees paid in stock. The transaction price was $1.529 per share.
After this grant, the director now beneficially owns 668,614 shares of LFT common stock, held directly. The filing indicates this was an acquisition of shares, not a sale, and there were no derivative securities reported in connection with this transaction.
Lument Finance Trust, Inc. (LFT) reported that one of its directors received company stock as part of director compensation. On 11/24/2025, the director acquired 8,992 shares of common stock, identified as an acquisition transaction, at a reported price of $1.529 per share, as payment of director fees in stock rather than cash.
Following this transaction, the director beneficially owns 162,116 shares of Lument Finance Trust common stock in direct ownership form. The filing notes that the shares reported were issued as director fees paid in stock, reflecting routine equity-based compensation rather than an open-market purchase or sale.